Hyperglycaemia definition | Mean MABC-2 score | Univariable | Multivariable | ||||
No hyperglycaemia (n) | Hyperglycaemia (n) | Difference in mean scores (95% CI) | P value | Difference in mean scores (95% CI) | P value | ||
>8 mmol/L | at least once | 73.49 (44) | 64.55 (301) | −8.94 (−14.67 to −3.22) | 0.002 | −4.73 (−10.20 to 0.74) | 0.090 |
on ≥2 consecutive days | 70.27 (129) | 62.99 (216) | −7.27 (−11.19 to −3.36) | <0.001 | −3.24 (−7.26 to 0.79) | 0.114 | |
on ≥3 consecutive days | 68.88 (204) | 61.09 (141) | −7.79 (−11.69 to −3.89) | <0.001 | −4.90 (−8.90 to −0.89) | 0.017 | |
Days with hyperglycaemia (per 1-day increase) | – | – | −0.84 (−1.15 to −0.53) | <0.001 | −0.55 (−0.93 to −0.17) | 0.005 | |
>10 mmol/L | at least once | 70.91 (114) | 63.16 (231) | −7.75 (−11.83 to −3.68) | <0.001 | −4.64 (−8.78 to −0.51) | 0.029 |
on ≥2 consecutive days | 69.48 (203) | 60.31 (142) | −9.17 (−13.04 to −5.29) | <0.001 | −5.87 (−9.94 to −1.79) | 0.005 | |
on ≥3 consecutive days | 68.17 (256) | 58.48 (89) | −9.69 (−14.09 to −5.29) | <0.001 | −6.05 (−10.71 to −1.39) | 0.011 | |
Days with hyperglycaemia (per 1-day increase) | – | – | −1.18 (−1.59 to −0.77) | <0.001 | −0.91 (−1.39 to −0.42) | <0.001 |
A random intercept was used to account for the clustering effect of twins/triplets. Adjusted for gestational age at birth, sex, occurrence of intraventricular haemorrhage grade 3–4 and/or periventricular leukomalacia, durations of mechanical ventilation and steroid treatments during the first 14 postnatal days, surgery due to patent ductus arteriosus or necrotising enterocolitis during the first 14 postnatal days, number of culture-verified sepsis episodes during the first 14 postnatal days, educational status of the mother, and age at follow-up. MABC-2 total scores ≤75 and ≤68 are equivalent to ≤15th centile (borderline motor impairment) and ≤5th centile (developmental coordination disorder) in Swedish children, respectively.